Alantolactone Activates the Extracellular Signal-Regulated Kinase Signaling Pathway to Promote Tumor Necrosis Factor Receptor 1 Ectodomain Shedding
Molecules · 2026
DOI: 10.3390/molecules31183296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Piimwara Yarangsee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biology, Kyoto Institute of Technology, Kyoto 606-8585, Japan. Hauptthemen laut MEDLINE: Sesquiterpenes, Eudesmane, Lactones, MAP Kinase Signaling System, Receptors, Tumor Necrosis Factor, Type I. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Alantolactone is a sesquiterpene lactone that possesses anticancer and anti-inflammatory properties. We previously demonstrated that several sesquiterpenes, including alantolactone, induced the ectodomain shedding of tumor necrosis factor receptor 1 (TNF-R1). In the present study, we investigated the upstream signaling pathway underlying alantolactone-induced TNF-R1 ectodomain shedding. Alantolactone down-regulated the expression of full-length TNF-R1 on the cell surface of human lung adenocarcinoma A549 cells, and this was accompanied by an increase in soluble TNF-R1 in the culture medium. TNF-R1 ectodomain shedding was also detected in human embryonic kidney 293T cells and human fibrosarcoma HT-1080 cells, indicating the conservation of this effect in multiple cell lines. The metalloproteinase inhibitor GM6001 markedly suppressed alantolactone-induced soluble TNF-R1 release and restored cell-surface TNF-R1 expression. Among specific inhibitors targeting mitogen-activated protein kinase (MAPK) signaling pathways, TNF-R1 ectodomain shedding was markedly suppressed by the MAPK/extracellular signal-regulated kinase (ERK) kinase (MEK) inhibitor U0126, whereas the suppressive effects of the c-Jun N-terminal kinase (JNK) inhibitor SP600125 or the p38 MAPK inhibitor SB203580 were negligible. Consistent with these results, alantolactone increased phospho-ERK and phospho-RAF1 levels within 60–120 min, while p38 MAPK and JNK were minimally phosphorylated during the 120-min incubation. Collectively, these results indicate that alantolactone-induced TNF-R1 ectodomain shedding is mediated by the activation of the RAF1–ERK signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Biology, Kyoto Institute of Technology, Kyoto 606-8585, Japan.
- Division of Molecular and Cellular Immunoscience, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
- Center for Social and Biomedical Engineering, Kyoto Institute of Technology, Kyoto 606-8585, Japan.
ORCID-Profile: Yasunobu Miyake, Takao Kataoka
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Yarangsee, P., Vu, Q. V., Miyake, Y., & Kataoka, T. (2026). Alantolactone Activates the Extracellular Signal-Regulated Kinase Signaling Pathway to Promote Tumor Necrosis Factor Receptor 1 Ectodomain Shedding. Molecules. https://doi.org/10.3390/molecules31183296
Vancouver
Yarangsee P, Vu QV, Miyake Y, Kataoka T. Alantolactone Activates the Extracellular Signal-Regulated Kinase Signaling Pathway to Promote Tumor Necrosis Factor Receptor 1 Ectodomain Shedding. Molecules. 2026. doi:10.3390/molecules31183296
BibTeX
@article{Yarangsee2026,
author = {Yarangsee, Piimwara and Vu, Quy Van and Miyake, Yasunobu and Kataoka, Takao},
title = {Alantolactone Activates the Extracellular Signal-Regulated Kinase Signaling Pathway to Promote Tumor Necrosis Factor Receptor 1 Ectodomain Shedding},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31183296}
}
EUVIMED